You are here » Home » Companies » Company Overview » Hester Biosciences Ltd

Hester Biosciences Ltd.

BSE: 524669 Sector: Health care
NSE: HESTERBIO ISIN Code: INE782E01017
BSE 00:00 | 24 Jan 1609.00 0
(0.00%)
OPEN

1609.00

HIGH

1616.85

LOW

1609.00

NSE 00:00 | 24 Jan 1605.40 -9.20
(-0.57%)
OPEN

1619.20

HIGH

1619.85

LOW

1600.00

OPEN 1609.00
PREVIOUS CLOSE 1609.00
VOLUME 17
52-Week high 2044.40
52-Week low 1043.25
P/E 32.03
Mkt Cap.(Rs cr) 1,369
Buy Price 1579.05
Buy Qty 1.00
Sell Price 1625.00
Sell Qty 1.00
OPEN 1609.00
CLOSE 1609.00
VOLUME 17
52-Week high 2044.40
52-Week low 1043.25
P/E 32.03
Mkt Cap.(Rs cr) 1,369
Buy Price 1579.05
Buy Qty 1.00
Sell Price 1625.00
Sell Qty 1.00

Hester Biosciences Ltd. (HESTERBIO) - Company History

Incorporated as a private limited company in Apr.'87, Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.'93. HPL markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium. The company's own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation. During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun. The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry vaccines.